Sanofi-GSK reports success in Covid-19 vaccine, after setback
Sanofi-GSK reports success in Covid-19 vaccine, after setback SECTIONS Last Updated: May 17, 2021, 01:45 PM IST Share Synopsis The drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval for the vaccine before the end of 2021. AFP GlaxoSmithKline's potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year. After two doses of the vaccine candidate, participants showed neutralis...